Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia.

@article{Nakanishi2008MonosodiumG,
  title={Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia.},
  author={Yuko J. Nakanishi and Koichi Tsuneyama and Makoto Fujimoto and Thucydides L. Salunga and Kazuhiro Nomoto and Jun-ling An and Yasuo Takano and Seiichi Iizuka and Mitsunobu Nagata and Wataru Suzuki and Tsutomu Shimada and Masaki Aburada and Masayuki Nakano and Carlo Selmi and M Eric Gershwin},
  journal={Journal of autoimmunity},
  year={2008},
  volume={30 1-2},
  pages={
          42-50
        }
}
  • Yuko J. Nakanishi, Koichi Tsuneyama, +12 authors M Eric Gershwin
  • Published 2008
  • Medicine
  • Journal of autoimmunity
  • Chronic inflammation is a common theme in a variety of disease pathways, including autoimmune diseases. [...] Key Result By 6 and 12 months of age, all MSG-treated mice developed NAFLD and NASH-like histology, respectively. In particular, the murine steatohepatitis at 12 months was virtually undistinguishable from human NASH. Further, dysplastic nodular lesions were detected in some cases within the fibrotic liver parenchyma. We submit that MSG treatment of mice induces obesity and diabetes with steatosis and…Expand Abstract

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 87 CITATIONS, ESTIMATED 65% COVERAGE

    Nonalcoholic steatohepatitis and hepatocellular carcinoma in galectin-3 knockout mice.

    FILTER CITATIONS BY YEAR

    2008
    2020

    CITATION STATISTICS

    • 4 Highly Influenced Citations

    • Averaged 8 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 48 REFERENCES

    Nonalcoholic steatohepatitis: definition and pathology.

    VIEW 1 EXCERPT

    Nonalcoholic fatty liver disease: a review of current understanding and future impact.

    • Michael R Charlton
    • Medicine
    • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
    • 2004
    VIEW 2 EXCERPTS

    Mouse models in non-alcoholic fatty liver disease and steatohepatitis research.

    VIEW 2 EXCERPTS

    Non-alcoholic steatohepatitis in children.

    VIEW 1 EXCERPT